Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: A MLK-3-MKK7-dependent mechanism
- 8 December 2007
- journal article
- Published by Elsevier BV in Cellular Signalling
- Vol. 20 (4), 675-683
- https://doi.org/10.1016/j.cellsig.2007.12.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Dynamic Positive Feedback Phosphorylation of Mixed Lineage Kinase 3 by JNK Reversibly Regulates Its Distribution to Triton-soluble DomainsJournal of Biological Chemistry, 2006
- Role of MLK3 in the Regulation of Mitogen-Activated Protein Kinase Signaling CascadesMolecular and Cellular Biology, 2005
- From JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical ImportanceIUBMB Life, 2005
- Role of JNK activation in apoptosis: A double-edged swordCell Research, 2005
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- A New Identity for MLK3 as an NIMA-related, Cell Cycle–regulated Kinase That Is Localized near Centrosomes and Influences Microtubule OrganizationMolecular Biology of the Cell, 2003
- Autoinhibition of Mixed Lineage Kinase 3 through Its Src Homology 3 DomainJournal of Biological Chemistry, 2001
- c-Jun NH2-terminal Kinase-mediated Redox-dependent Degradation of IκBPublished by Elsevier BV ,2001
- Signal Transduction by the JNK Group of MAP KinasesCell, 2000
- A Conserved Binding Motif Defines Numerous Candidate Target Proteins for Both Cdc42 and Rac GTPasesJournal of Biological Chemistry, 1995